Anti-SO1B3/ SLCO1B3/ HBLRR monoclonal antibody

Anti-SO1B3/ SLCO1B3/ HBLRR antibody for FACS & in-vivo assay

Target products collectionGo to SLCO1B3/SLCO1B3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T02565-Ab-1/ GM-Tg-hg-T02565-Ab-2Anti-Human SLCO1B3 monoclonal antibodyHuman
GM-Tg-rg-T02565-Ab-1/ GM-Tg-rg-T02565-Ab-2Anti-Rat SLCO1B3 monoclonal antibodyRat
GM-Tg-mg-T02565-Ab-1/ GM-Tg-mg-T02565-Ab-2Anti-Mouse SLCO1B3 monoclonal antibodyMouse
GM-Tg-cynog-T02565-Ab-1/ GM-Tg-cynog-T02565-Ab-2Anti-Cynomolgus/ Rhesus macaque SLCO1B3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T02565-Ab-1/ GM-Tg-felg-T02565-Ab-2Anti-Feline SLCO1B3 monoclonal antibodyFeline
GM-Tg-cang-T02565-Ab-1/ GM-Tg-cang-T02565-Ab-2Anti-Canine SLCO1B3 monoclonal antibodyCanine
GM-Tg-bovg-T02565-Ab-1/ GM-Tg-bovg-T02565-Ab-2Anti-Bovine SLCO1B3 monoclonal antibodyBovine
GM-Tg-equg-T02565-Ab-1/ GM-Tg-equg-T02565-Ab-2Anti-Equine SLCO1B3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T02565-Ab-1/ GM-Tg-hg-T02565-Ab-2; GM-Tg-rg-T02565-Ab-1/ GM-Tg-rg-T02565-Ab-2;
GM-Tg-mg-T02565-Ab-1/ GM-Tg-mg-T02565-Ab-2; GM-Tg-cynog-T02565-Ab-1/ GM-Tg-cynog-T02565-Ab-2;
GM-Tg-felg-T02565-Ab-1/ GM-Tg-felg-T02565-Ab-2; GM-Tg-cang-T02565-Ab-1/ GM-Tg-cang-T02565-Ab-2;
GM-Tg-bovg-T02565-Ab-1/ GM-Tg-bovg-T02565-Ab-2; GM-Tg-equg-T02565-Ab-1/ GM-Tg-equg-T02565-Ab-2
Products NameAnti-SLCO1B3 monoclonal antibody
Formatmab
Target NameSLCO1B3
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLCO1B3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species SO1B3/ SLCO1B3/ HBLRR VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLV000089human SLCO1B3 Lentivirus particle
    ORF Viral VectorpGMLV000089human SLCO1B3 Lentivirus plasmid


    Target information

    Target IDGM-T02565
    Target NameSLCO1B3
    Gene ID28234,28253,58978,574354,100068155
    Gene Symbol and Synonyms7330442B20Rik,HBLRR,lst-1,LST-2,LST-3™13,LST3,mlst-1,OATP-4,OATP-8,OATP-C,Oatp1b2,OATP1B3,Oatp1b4,OATP2,Oatp4,OATP8,OATPC,rlst-1,Slc21a10,Slc21a6,SLC21A8,Slco1b2,SLCO1B3,Slco1b4
    Uniprot AccessionQ9NPD5,Q9QZX8
    Uniprot Entry NameSO1B3_HUMAN,SO1B2_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000111700
    Target ClassificationTumor-associated antigen (TAA)

    The target: SLCO1B3, gene name: SLCO1B3, also named as HBLRR, LST-2, LST-3™13, LST3, OATP-8, OATP1B3, OATP8, SLC21A8. This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of endogenous and xenobiotic compounds and plays a critical role in bile acid and bilirubin transport. Mutations in this gene are a cause of Rotor type hyperbilirubinemia. Alternative splicing of this gene and the use of alternative promoters results in transcript variants encoding different isoforms that differ in their tissue specificity. [provided by RefSeq, Mar 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.